February 17, 2016

The Netherlands Ministry of Foreign Affairs will provide 16 million Euros (approximately US$18 million) to IAVI over five years to help accelerate the development of AIDS vaccine candidates effective for and accessible to the people most impacted by the epidemic, notably those in developing countries. This support under the Product Development Partnership III Fund extends through September 2020.
 
Since 1999, generous support from the Dutch Government has helped IAVI to achieve and facilitate significant progress in AIDS vaccine research and to strengthen collaborations, infrastructure and expertise, particularly in eastern and southern Africa and India, to help accelerate the research.
 
“We are proud to continue our valuable and fruitful relationship with IAVI,” said Lambert Grijns, Director, Social Development Department (DSO), Ministry of Foreign Affairs. “IAVI’s innovative partnership model brings together an extensive range of the world’s best experts from academia, government and industry to accelerate progress toward a vaccine to help prevent HIV/AIDS.”
 
“We applaud the Dutch Government’s continued leadership in fighting HIV/AIDS and in working to improve the health and human rights of some of the world’s most vulnerable people,” said Mark Feinberg, IAVI President and CEO. “We are very grateful for their support and proud to continue our work together toward a vaccine and a world without AIDS.”

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

Global

Anita Kawatra
+1 212 847 1055
AKawatra@iavi.org 

 

India

Saif ul Hadi
+91 11 4737 6032
SulHadi@iavi.org 

 

United States

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org